Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed Papers
Cancer specific risk in multiple sclerosis patients.
Clemastine Enhances Myelination in the Prefrontal Cortex and Rescues Behavioral Changes in Socially Isolated Mice.
Eomesodermin-expressing T-helper cells are essential for chronic neuroinflammation.
Gender differences in multiple sclerosis: induction of estrogen signaling in male and progesterone signaling in female lesions.
A case of fulminant neuromyelitis optica presenting with destructive lesions in whole-brain.
Responsiveness of selected outcome measures of participation restriction and quality of life in patients with multiple sclerosis.
Whom to Target for Falls-Prevention Trials: Recommendations from the International MS Falls Prevention Research Network.
Why are prions and amyloid structures immune suppressive and other intriguing questions facing neuroimmunologists in the future.
Very late-onset neuromyelitis optica spectrum disorder beyond the age of 75.
A preliminary study of functional imaging upon placebo analgesia in progressive multiple sclerosis.
Obesity interacts with infectious mononucleosis in risk of multiple sclerosis.
A new CSF1R mutation presenting with an extensive white matter lesion mimicking primary progressive multiple sclerosis.
Disease exacerbation after rituximab induction in neuromyelitis optica.
Intranasal brain delivery of cationic nanoemulsion-encapsulated TNFα siRNA in prevention of experimental neuroinflammation.
Epstein Barr Virus and Mycobacterium avium subsp. paratuberculosis peptides are recognized in sera and cerebrospinal fluid of MS patients.
Influence of the LILRA3 Deletion on Multiple Sclerosis Risk: Original Data and Meta-Analysis.
Protoporphyrin Treatment Modulates Susceptibility to Experimental Autoimmune Encephalomyelitis in miR-155-Deficient Mice.
Diagnostic accuracy of current sonographic criteria for the detection of outflow abnormalities in the internal jugular veins.
[The treatment by expanded ex vivo autologous regulatory T-cells CD4+CD25+FoxP3+CD127low restores the balance of immune system in patients with remitting-relapsing multiple sclerosis].
Role of Glia in Stress-Induced Enhancement and Impairment of Memory.
Electrodiagnostics and clinical correlates in acquired polyneuropathies.
Spatio-Temporal Patterns of Demyelination and Remyelination in the Cuprizone Mouse Model.
Improved Characterization of Visual Evoked Potentials in Multiple Sclerosis by Topographic Analysis.
Cerebrospinal fluid and serum JC virus antibody detection in multiple sclerosis patients treated with natalizumab.
An unusual case of 'itchy paralysis': neuromyelitis optica presenting with severe neuropathic itch.
Pages
« first
‹ previous
…
622
623
624
625
626
627
628
629
630
…
next ›
last »